1887
  1. Home
  2. Eurosurveillance
  3. Volume 24, Issue 40, 03/Oct/2019
  4. Article
Research Open Access
Like 0
Download

Abstract

Background

Universal antenatal HIV screening programmes are an effective method of preventing mother-to-child transmission.

Aims

To assess the coverage and yield of the French programme on a nationally representative sample of pregnant women, and predictive factors for being unscreened or missing information on the performance/ result of a HIV test.

Methods

Data came from the medical records of women included in the cross-sectional 2016 French National Perinatal Survey. We calculated odds ratios (OR) to identify factors for being unscreened for HIV and for missing information by multivariable analyses.

Results

Of 13,210 women, 12,782 (96.8%) were screened for HIV and 134 (1.0%) were not; information was missing for 294 (2.2%). HIV infection was newly diagnosed in 19/12,769 (0.15%) women screened. The OR for being unscreened was significantly higher in women in legally registered partnerships (OR: 1.3; 95% CI: 1.1–1.6), with 1–2 years of post-secondary schooling (OR: 1.6; 95% CI: 1.2–2.1), part-time employment (OR: 1.4; 95% CI: 1.1–1.8), inadequate antenatal care (OR: 1.9; 95% CI: 1.5–2.4) and receiving care from > 1 provider (OR: 1.8; 95% CI: 1.1–2.8). The OR of missing information was higher in multiparous women (OR: 1.4; 95% CI: 1.2–1.5) and women cared for by general practitioners (OR: 1.4; 95% CI: 1.1–1.9).

Conclusions

The French antenatal HIV screening programme is effective in detecting HIV among pregnant women. However, a few women are still not screened and awareness of the factors that predict this could contribute to improved screening levels.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2019.24.40.1800573
2019-10-03
2024-12-21
/content/10.2807/1560-7917.ES.2019.24.40.1800573
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/24/40/eurosurv-24-40-2.html?itemId=/content/10.2807/1560-7917.ES.2019.24.40.1800573&mimeType=html&fmt=ahah

References

  1. Haute Autorité de Santé (HAS). Suivi et orientation des femmes enceintes en fonction des situations à risque identifiées. [Follow-up and orientation of pregnant women according to identified risk exposures]. Paris: HAS. [Accessed 8 Oct 2018]. French. Available from: https://www.has-sante.fr/portail/jcms/c_547976/fr/suivi-et-orientation-des-femmes-enceintes-en-fonction-des-situations-a-risque-identifiees
  2. Haute Autorité de Santé (HAS). Réévaluation de la stratégie de dépistage de l'infection à VIH en France. [Reassessment of the HIV screening strategy in France]. Paris: HAS. [Accessed 22 Jan 2019]. French. Available from: https://www.has-sante.fr/portail/upload/docs/application/pdf/2017-03/dir2/reevaluation_de_la_strategie_depistage_vih_-_synthese_conclusions_reco.pdf
  3. Conseil national du sida et des hépatites virales (CNS). Mandelbrot L. Désir d'enfant et grossesse. Prise en charge médicale des personnes vivant avec le VIH - Recommandations du groupe d’experts sous la direction du Pr Philippe Morlat. [Child’s desire and pregnancy. Medical management of people living with HIV. Recommendations of the experts group directed by Philippe Morlat]. Paris: CNS; [Accessed 22 Jan 2019]. French. Available from: https://cns.sante.fr/actualites/prise-en-charge-du-vih-recommandations-du-groupe-dexperts/
  4. Jasseron C. Prise en charge des femmes enceintes infectées par le VIH en France à l’ère des multithérapies : des recommandations aux pratiques. [Access to prevention of mother to child HIV transmission in the multitherapy area: implementation of the guidelines]. Paris. [Accessed 24 Sep 2019]. French. Available from: http://www.theses.fr/2012PA11T078
  5. Navér L, Lindgren S, Belfrage E, Gyllensten K, Lidman K, Gisslén M, et al. Children born to HIV-1-infected women in Sweden in 1982-2003: trends in epidemiology and vertical transmission. J Acquir Immune Defic Syndr. 2006;42(4):484-9.  https://doi.org/10.1097/01.qai.0000224571.30119.3d  PMID: 16810115 
  6. Patterson KB, Leone PA, Fiscus SA, Kuruc J, McCoy SI, Wolf L, et al. Frequent detection of acute HIV infection in pregnant women. AIDS. 2007;21(17):2303-8.  https://doi.org/10.1097/QAD.0b013e3282f155da  PMID: 18090278 
  7. Op de Coul EL, Hahné S, van Weert YW, Oomen P, Smit C, van der Ploeg KP, et al. Antenatal screening for HIV, hepatitis B and syphilis in the Netherlands is effective. BMC Infect Dis. 2011;11(1):185.  https://doi.org/10.1186/1471-2334-11-185  PMID: 21718466 
  8. Townsend CL, Byrne L, Cortina-Borja M, Thorne C, de Ruiter A, Lyall H, et al. Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011. AIDS. 2014;28(7):1049-57.  https://doi.org/10.1097/QAD.0000000000000212  PMID: 24566097 
  9. Frange P, Chaix ML, Veber F, Blanche S. Missed opportunities for HIV testing in pregnant women and children living in France. Pediatr Infect Dis J. 2014;33(2):e60-2.  https://doi.org/10.1097/INF.0b013e3182a09120  PMID: 24108234 
  10. Peters H, Thorne C, Tookey PA, Byrne L. National audit of perinatal HIV infections in the UK, 2006-2013: what lessons can be learnt? HIV Med. 2018;19(4):280-9.  https://doi.org/10.1111/hiv.12577  PMID: 29336508 
  11. Valle S, Pezzotti P, Floridia M, Pellegrini MG, Bernardi S, Puro V, et al. Percentage and determinants of missed HIV testing in pregnancy: a survey of women delivering in the Lazio region, Italy. AIDS Care. 2014;26(7):899-906.  https://doi.org/10.1080/09540121.2013.861572  PMID: 24279737 
  12. Pauly F, Freese AL, Golic M, Henrich W, Weizsaecker K. Testing for HIV during pregnancy: 5 years after changing German pregnancy guidelines. Arch Gynecol Obstet. 2013;288(1):29-32.  https://doi.org/10.1007/s00404-013-2744-9  PMID: 23385348 
  13. Blondel B, Lelong N, Kermarrec M, Goffinet F, Coordination nationale des Enquêtes Nationales Périnatales. La santé périnatale en France métropolitaine de 1995 à 2010. Résultats des enquêtes nationales périnatales [Trends in perinatal health in France between 1995 and 2010: Results from the National Perinatal Surveys]. J Gynecol Obstet Biol Reprod (Paris). 2012;41(2):151-66.  https://doi.org/10.1016/j.jgyn.2011.11.008  PMID: 22197351 
  14. Blondel B, Coulm B, Bonnet C, Goffinet F, Le Ray C, National Coordination Group of the National Perinatal Surveys. Trends in perinatal health in metropolitan France from 1995 to 2016: Results from the French National Perinatal Surveys. J Gynecol Obstet Hum Reprod. 2017;46(10):701-13.  https://doi.org/10.1016/j.jogoh.2017.09.002  PMID: 29031048 
  15. Breese P, Burman W, Shlay J, Guinn D. The effectiveness of a verbal opt-out system for human immunodeficiency virus screening during pregnancy. Obstet Gynecol. 2004;104(1):134-7.  https://doi.org/10.1097/01.AOG.0000129957.35105.d4  PMID: 15229012 
  16. Cazein F, Le Strat F, Sarr A, Ramus C, Bouche N, Comboroure JC, et al. Dépistage de l’infection par le VIH en France en 2016. Bull Epidemiol Hebd (Paris). 2017; (29-30):601-8.
  17. Lee KJ, Carlin JB. Multiple imputation for missing data: fully conditional specification versus multivariate normal imputation. Am J Epidemiol. 2010;171(5):624-32.  https://doi.org/10.1093/aje/kwp425  PMID: 20106935 
  18. Wu Y, Jiang X, Wang S, Jiang W, Li P, Ohno-Machado L. Grid multi-category response logistic models. BMC Med Inform Decis Mak. 2015;15(1):10.  https://doi.org/10.1186/s12911-015-0133-y  PMID: 25886151 
  19. Carayol M, Bucourt M, Cuesta J, Blondel B, Zeitlin J. Les femmes de Seine-Saint-Denis ont-elles un suivi prénatal différent de celui des autres femmes d’Île-de-France? [Do women from Seine-Saint-Denis have different prenatal care compared to other women in the region?]. J Gynecol Obstet Biol Reprod (Paris). 2015;44(3):258-68.  https://doi.org/10.1016/j.jgyn.2014.02.006  PMID: 24702967 
  20. Feijen-de Jong EI, Jansen DE, Baarveld F, van der Schans CP, Schellevis FG, Reijneveld SA. Determinants of late and/or inadequate use of prenatal healthcare in high-income countries: a systematic review. Eur J Public Health. 2012;22(6):904-13.  https://doi.org/10.1093/eurpub/ckr164  PMID: 22109988 
  21. Frew PM, Parker K, Vo L, Haley D, O’Leary A, Diallo DD, et al. , HIV Prevention Trials Network 064 (HTPN) Study Team. Socioecological factors influencing women’s HIV risk in the United States: qualitative findings from the women’s HIV SeroIncidence study (HPTN 064). BMC Public Health. 2016;16(1):803.  https://doi.org/10.1186/s12889-016-3364-7  PMID: 27530401 
  22. Conseil économique, social et environnemental. Le travail à temps partiel. [Economic, Social and Environmental Council. Part-time work]. Paris: Les éditions des journaux officiels. [Accessed 12 Oct 2018]. Available from: https://www.lecese.fr/travaux-publies/le-travail-temps-partiel-0
  23. Conseil national du sida et des hépatites virales (CNS). Costagliola D. Epidémiologie de l'infection à VIH en France. Prise en charge médicale des personnes vivant avec le VIH - Recommandations du groupe d’experts sous la direction du Pr Philippe Morlat. [Epidemiology of HIV in France. Medical management of people living with HIV directed by Philippe Morlat]. Paris: CNS; [Accessed 22 Jan 2019]. French. Available from: https://cns.sante.fr/actualites/prise-en-charge-du-vih-recommandations-du-groupe-dexperts/
Antenatal HIV screening: results from the National Perinatal Survey, France, 2016
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Thi-Chi%C3%AAn+Tran&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Tran Thi-Chiên</a>, <a href="/search?value1=Josiane+Pillonel&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Pillonel Josiane</a>, <a href="/search?value1=Fran%C3%A7oise+Cazein&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Cazein Françoise</a>, <a href="/search?value1=C%C3%A9cile+Sommen&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Sommen Cécile</a>, <a href="/search?value1=Camille+Bonnet&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Bonnet Camille</a>, <a href="/search?value1=B%C3%A9atrice+Blondel&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Blondel Béatrice</a>, <a href="/search?value1=Florence+Lot&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Lot Florence</a></span>. Antenatal HIV screening: results from the National Perinatal Survey, France, 2016. <a href="/content/ecdc">Euro Surveill.</a> 2019;24(40):pii=1800573. <a href="https://doi.org/10.2807/1560-7917.ES.2019.24.40.1800573" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2019.24.40.1800573</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 12 Oct 2018;&nbsp;&nbsp; <span class="generated">Accepted</span>: 20 Feb 2019 </span> </p>
/content/10.2807/1560-7917.ES.2019.24.40.1800573
/content/10.2807/1560-7917.ES.2019.24.40.1800573
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error